Moreover, ANXA1 is a glucocorticoid‐modulated anti‐inflammatory protein that plays a key role in IBD control and is a potential biomarker of IBD progression,63 possibly contributing to HAEC. This evidence concerns the gene ANXA1 and inflammatory bowel disease.